Amarin Corp Plc (AMRN)

[heysfguy]

Getting "60 Minutes" to do a piece on Amarin/EPA is probably too narrow a focus for them. THAT SAID, they MIGHT be much more interested in doing a piece on the Statin industry and its influence on everyone from practitioners all the way up to the FDA. That's when EPA (and possibly Amarin history) might come in handy for them. Regardless of whether or not Amarin gets mentioned, it might help build positive awareness of EPA alternatives - and possible help boost sales long term. And that might well be worth the effort. There's plenty of disagreement brewing over the role of statins - and it might be a good story for 60 Minutes, esp. due to their viewer demographics.